FRANKLIN RESOURCES INC - ACLARIS THERAPEUTICS INC ownership

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 101 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$611,000
-7.3%
41,994
+14.7%
0.00%
Q3 2021$659,000
-92.2%
36,600
-99.0%
0.00%
-100.0%
Q2 2019$8,421,000
-64.9%
3,845,423
-4.0%
0.00%
-69.2%
Q1 2019$23,989,000
-18.6%
4,004,814
+0.5%
0.01%
-27.8%
Q4 2018$29,459,000
-30.0%
3,986,422
+37.5%
0.02%
-14.3%
Q3 2018$42,084,000
-29.1%
2,898,310
-2.4%
0.02%
-30.0%
Q2 2018$59,321,000
+31.5%
2,970,465
+15.3%
0.03%
+30.4%
Q1 2018$45,121,000
-29.5%
2,575,391
-0.8%
0.02%
-25.8%
Q4 2017$64,037,000
+22.2%
2,596,814
+27.9%
0.03%
+19.2%
Q3 2017$52,417,000
-1.2%
2,030,869
+3.9%
0.03%0.0%
Q2 2017$53,030,000
+41.3%
1,955,381
+55.4%
0.03%
+36.8%
Q1 2017$37,522,000
-9.5%
1,258,277
-17.6%
0.02%
-9.5%
Q4 2016$41,457,000
+3.3%
1,527,549
-2.5%
0.02%0.0%
Q3 2016$40,144,000
+38.0%
1,567,513
-0.5%
0.02%
+31.2%
Q2 2016$29,088,000
-6.4%
1,574,884
-3.9%
0.02%0.0%
Q1 2016$31,067,000
-30.3%
1,639,454
-0.9%
0.02%
-30.4%
Q4 2015$44,583,0001,654,8940.02%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Endurant Capital Management LP 1,769,785$1,911,0000.69%
Telemetry Investments, L.L.C. 214,593$232,0000.67%
Aisling Capital Management LP 634,455$685,0000.36%
Broadfin Capital, LLC 1,620,000$1,750,0000.32%
MFN Partners Management, LP 1,500,000$1,620,0000.24%
Sofinnova Investments, Inc. 1,911,573$2,064,0000.19%
Rock Springs Capital Management LP 2,974,754$3,213,0000.13%
Alambic Investment Management, L.P. 150,636$163,0000.12%
Cormorant Asset Management, LP 250,000$270,0000.02%
Man Group plc 3,734,793$4,034,0000.02%
View complete list of ACLARIS THERAPEUTICS INC shareholders